awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q33504409-4F466F76-A65E-4D5B-AA41-42BB9930FCE6
Q33504409-4F466F76-A65E-4D5B-AA41-42BB9930FCE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33504409-4F466F76-A65E-4D5B-AA41-42BB9930FCE6
A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion.
P304
Q33504409-4F466F76-A65E-4D5B-AA41-42BB9930FCE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33504409-4F466F76-A65E-4D5B-AA41-42BB9930FCE6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a153465d02e89cf92ff08385dbc673ebc5e84e5e
P304
1329-1336
http://www.w3.org/2001/XMLSchema#string